This information is intended for healthcare professionals only. Please confirm that you are a healthcare professional.
I confirm that I am a healthcare professional
Note: OncoSil™ is currently approved in the European Union, the United Kingdom, Hong Kong, Singapore, Malaysia and New Zealand.
OncoSil™ is a single-use brachytherapy device comprising phosphorus-32 (32P) silicon microparticles suspended in a specially formulated diluent.
OncoSil™ is a single-use brachytherapy device which comprises of Phosphorous-32 (32P) Microparticles suspended in a specially formulated Diluent.
OncoSil™ in pancreatic cancer
OncoSil™ has been studied in two clinical trials in unresectable locally advanced pancreatic cancer
Review OncoSil™ publications and conference presentations
Getting started with OncoSil™
Learn how to get started with OncoSil™ in your treatment facility